Table 4.
Hazard Ratios of All-cause and cause-specific mortality by number of vessels and Index of Diffusion (ID)
Model 1 | Model 2 | |||||
---|---|---|---|---|---|---|
All-Cause Mortality | CVD-specific Mortality | CHD-specific Mortality | All-Cause Mortality | CVD-specific Mortality | CHD-specific Mortality | |
Vessel Number | ||||||
1-Vessel | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) |
2-Vessel | 1.1 (0.9 to 1.4) |
1.4 (0.9 to 1.9) |
2.0
(1.1 to 3.6) |
1.1 (0.9 to 1.3) |
1.3 (0.9 to 1.9) |
1.9
(1.1 to 3.4) |
3-Vessel |
1.3
(1.1 to 1.5) |
1.8
(1.3 to 2.5) |
2.7
(1.6 to 4.7) |
1.2
(1.04 to 1.5) |
1.7
(1.2 to 2.4) |
2.6
(1.5 to 4.5) |
4-Vessel |
1.4
(1.1 to 1.7) |
2.0
(1.3 to 2.8) |
2.7
(1.5 to 4.9) |
1.3
(1.1 to 1.6) |
1.8
(1.2 to 2.6) |
2.5
(1.4 to 4.5) |
Index of Diffusion (Only ≥ 2 vessels) | ||||||
Concentrated | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) |
Normal | 1.04 (0.9 to 1.2) |
1.2 (0.9 to 1.6) |
0.9 (0.6 to 1.2) |
1.02 (0.9 to 1.2) |
1.2 (0.9 to 1.6) |
0.9 (0.6 to 1.3) |
Diffuse | 1.2 (0.97 to 1.4) |
1.5
(1.1 to 2.1) |
1.3 (0.8 to 2.0) |
1.2 (0.95 to 1.4) |
1.4
(1.02 to 2.0) |
1.2 (0.8 to 19) |
Model 1 includes age (as a continuous variable), sex, study site, baseline statin use, and Agatston CAC score (continuous).
Model 2 includes Model 1 + hypertension, dyslipidemia, and diabetes
CVD mortality includes the following: other circulatory disorder, CHD, stroke, and congestive heart failure.